A year on topical Fin .3%/Min .6% and .5mg Dut ED…no progress 24M Finasteride/Dutasteride 3/14/2025
A 24-year-old has seen no progress in hair loss treatment after a year using topical finasteride 0.3%, minoxidil 0.6%, and 0.5mg dutasteride daily. They experienced side effects from oral minoxidil and are seeking advice on next steps without adding RU58841.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Finasteride and Topical Minoxidil to Dutasteride and Oral Minoxidil. Is RU58841 still helping?
The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, questioning the effectiveness and safety of continuing RU58841. They experienced hair loss improvement initially but are now considering stopping RU58841 due to cost and safety concerns.
community Adding Topical Dutasteride on top of Oral Finasteride & Oral Minoxidil (19m)
The user experienced gradual hair thinning since 2021 and tried various treatments including topical minoxidil, rosemary oil, oral finasteride, oral minoxidil, RU58841, and oral dutasteride. They are considering switching to daily finasteride and adding topical dutasteride, tretinoin, and microneedling due to side effects from oral dutasteride.
community Hair loss still progressing despite finasteride, dutasteride, oral minoxidil, and trying RU58841. What next?
Despite using finasteride, dutasteride, oral minoxidil, and RU58841, hair loss continues to progress. Options considered include increasing dutasteride or minoxidil doses, adding topical treatments, and exploring other potential causes of hair loss.
community September - december with fin + oral & topical min + ru58841.
The user experienced hair regrowth using finasteride, oral and topical minoxidil, and RU58841, despite initial shedding. They also transitioned from finasteride to dutasteride and addressed scalp issues with a folliculitis shampoo.
community Nuclear stack: 2.5mg dutasteride vs 0.5mg dutasteride + topical finasteride/dutasteride/spironolactone for male pattern baldness
The conversation discusses using 2.5mg dutasteride, 0.5mg dutasteride with topical treatments, and other combinations like oral minoxidil, RU58841, and microneedling for male pattern baldness. Users share experiences and suggest various treatment regimens, emphasizing the effectiveness of dutasteride and minoxidil.
community 5 year progress on fin/dut and topical/oral minoxidil
The user shared their 5-year hair regrowth journey using oral finasteride, oral dutasteride, topical and oral minoxidil, and a hair transplant. They experienced significant hair improvement without major side effects, although RU58841 was not effective for them.
Related Research
6 / 6 resultsresearch CLINICAL UPDATES IN HAIR
This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.
research Системная терапия больных андрогенетической алопецией
Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.
research Тіе Modern treatment of androgenetic alopecia
This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.
research Therapeutic strategies for treating hair loss
This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.
research Hair growth and rejuvenation: An overview
This review discusses recent advancements in hair rejuvenation strategies and assesses the potential of herbal drugs as safer alternatives, but reports no new clinical results.
research The role of androgen and androgen receptor in skin-related disorders
This review discusses the roles of androgens and androgen receptors in skin-related disorders and suggests that targeting androgen receptors may be a more effective treatment strategy.